TF-343 Recovered Cyclophosphamide-Induced Compromised Immune Status in a Mouse Model
Journal of Microbiology and Biotechnology · 2025
DOI: 10.4014/jmb.2506.06034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2025. Verfasst von Gun-Dong Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Division of Food Functionality, Korea Food Research Institute (KFRI), Wanju 55365, Republic of Korea. Hauptthemen laut MEDLINE: Cyclophosphamide, Immunosuppressive Agents, Plant Extracts. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Food Industry Promotion Agency of Korea, Korea Food Research Institute, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Cyclophosphamide (CP) exerts potent cytostatic and immunosuppressive effects by inhibiting the proliferation and function of tumor and immune cells, thereby being widely used for therapeutic approaches and molecular mechanism studies in immunocompromised models and autoimmune disease models. TF-343 is a mixed extract derived from medicinal plants with anti-inflammatory and antioxidant properties and exhibits anti-inflammatory activity by modulating signaling pathways associated with immune responses. To elucidate the potential immunomodulatory effects and underlying mechanisms of TF-343 in more detail, we investigated its efficacy in a CP-induced immunosuppressive mouse model. Administered TF-343 significantly recovered CP-induced decreases in body weight and organ indices, including those of the thymus and spleen. The CP-mediated decrease in the number of lymphocytes and white blood cells and immunoglobulin production were restored by TF-343 administration. Furthermore, TF-343 enhanced the proliferation of total splenocytes and their subpopulations, including T and B lymphocytes. The administration of TF-343 promoted the function of natural killer cells and macrophages in CP-induced immunocompromised mice. Additionally, TF-343 supplementation reverted the CP-elicited downregulation of interleukin 2 and interferon γ mRNA and protein expression in splenocytes. Therefore, our results demonstrate that TF-343 enhances immune function and has potential as an immunoregulatory substance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Division of Food Functionality, Korea Food Research Institute (KFRI), Wanju 55365, Republic of Korea.
- Department of Food Biotechnology, Korea University of Science and Technology (UST), Daejeon 34113, Republic of Korea.
- Sungkyun Biotech Co., Ltd., Suwon 16648, Republic of Korea.
Förderung
- Food Industry Promotion Agency of Korea
- Korea Food Research Institute
- Ministry of Science and ICT, South Korea
Zitieren
APA
Kim, G. D., Yoo, S. H., Lim, K. M., Song, J. H., Kim, S., Lee, S. Y., Kim, S. H., & Shin, H. S. (2025). TF-343 Recovered Cyclophosphamide-Induced Compromised Immune Status in a Mouse Model. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2506.06034
Vancouver
Kim GD, Yoo SH, Lim KM, Song JH, Kim S, Lee SY, et al. TF-343 Recovered Cyclophosphamide-Induced Compromised Immune Status in a Mouse Model. Journal of Microbiology and Biotechnology. 2025. doi:10.4014/jmb.2506.06034
BibTeX
@article{Kim2025,
author = {Kim, Gun-Dong and Yoo, Sang Hyuk and Lim, Kyung Min and Song, Ju Hye and Kim, Seungil and Lee, So-Young and Kim, Seon-Hee and Shin, Hee Soon},
title = {TF-343 Recovered Cyclophosphamide-Induced Compromised Immune Status in a Mouse Model},
journal = {Journal of Microbiology and Biotechnology},
year = {2025},
doi = {10.4014/jmb.2506.06034}
}
EUVIMED